Roep BO - Search Results

1

Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?).

Roep BO, Thomaidou S, van Tienhoven R, Zaldumbide A. Roep BO, et al. Nat Rev Endocrinol. 2021 Mar;17(3):150-161. doi: 10.1038/s41574-020-00443-4. Epub 2020 Dec 8. Nat Rev Endocrinol. 2021. PMID: 33293704 Free PMC article. Review.

2

T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins.

Roep BO, Arden SD, de Vries RR, Hutton JC. Roep BO, et al. Nature. 1990 Jun 14;345(6276):632-4. doi: 10.1038/345632a0. Nature. 1990. PMID: 2190098

3

T-cell recognition of beta-cell autoantigens in insulin-dependent diabetes mellitus.

Kallan AA, de Vries RR, Roep BO. Kallan AA, et al. Among authors: roep bo. APMIS. 1996 Jan;104(1):3-11. doi: 10.1111/j.1699-0463.1996.tb00679.x. APMIS. 1996. PMID: 8645454 Review.

4

Autoreactive and immunoregulatory T-cell subsets in insulin-dependent diabetes mellitus.

Peterson LD, van der Keur M, de Vries RR, Roep BO. Peterson LD, et al. Among authors: roep bo. Diabetologia. 1999 Apr;42(4):443-9. doi: 10.1007/s001250051177. Diabetologia. 1999. PMID: 10230648

5

Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.

Roep BO, Atkinson MA, van Endert PM, Gottlieb PA, Wilson SB, Sachs JA. Roep BO, et al. J Autoimmun. 1999 Sep;13(2):267-82. doi: 10.1006/jaut.1999.0312. J Autoimmun. 1999. PMID: 10479395

6

T-cell assays to determine disease activity and clinical efficacy of immune therapy in type 1 diabetes.

van de Linde P, Roep BO. van de Linde P, et al. Among authors: roep bo. Am J Ther. 2005 Nov-Dec;12(6):573-9. doi: 10.1097/01.mjt.0000178768.44987.cb. Am J Ther. 2005. PMID: 16280651 Review.

7

The association between autoimmune thyroiditis, autoimmune gastritis and type 1 diabetes.

Lam-Tse WK, Batstra MR, Koeleman BP, Roep BO, Bruining MG, Aanstoot HJ, Drexhage HA. Lam-Tse WK, et al. Among authors: roep bo. Pediatr Endocrinol Rev. 2003 Sep;1(1):22-37. Pediatr Endocrinol Rev. 2003. PMID: 16437010 Review.

8

Immune markers of disease and therapeutic intervention in type 1 diabetes.

Roep BO. Roep BO. Novartis Found Symp. 2008;292:159-71; discussion 171-3, 202-3. doi: 10.1002/9780470697405.ch15. Novartis Found Symp. 2008. PMID: 19203098

9

Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes.

Roep BO, Peakman M. Roep BO, et al. Nat Rev Immunol. 2010 Feb;10(2):145-52. doi: 10.1038/nri2705. Nat Rev Immunol. 2010. PMID: 20098462 Review.

10

Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells.

Kleijwegt FS, Laban S, Duinkerken G, Joosten AM, Zaldumbide A, Nikolic T, Roep BO. Kleijwegt FS, et al. Among authors: roep bo. J Immunol. 2010 Aug 1;185(3):1412-8. doi: 10.4049/jimmunol.1000560. Epub 2010 Jun 23. J Immunol. 2010. PMID: 20574005

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters